You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 28, 2025

Drug Price Trends for NDC 51407-0623


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 51407-0623

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
NIFEDIPINE (EQV-CC) 60MG TAB,SA Golden State Medical Supply, Inc. 51407-0623-03 300 18.98 0.06327 2023-06-15 - 2028-06-14 FSS
NIFEDIPINE (EQV-CC) 60MG TAB,SA Golden State Medical Supply, Inc. 51407-0623-01 100 6.33 0.06330 2023-06-15 - 2028-06-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 2 of 2 entries

Market Analysis and Price Projections for Nifedipine (NDC: 51407-0623)

Introduction

Nifedipine, a calcium channel blocker, is widely used to treat hypertension and angina. The National Drug Code (NDC) 51407-0623 corresponds to Nifedipine 60mg tablets, supplied by Golden State Medical Supply, Inc. Here, we will delve into the market analysis and price projections for this specific formulation.

Current Pricing and Trends

As of the latest data, the wholesale prices for Nifedipine 60mg tablets (NDC: 51407-0623) are as follows:

  • Price per Unit: Approximately $0.06327 per unit for a pack of 300 tablets[1].
  • Total Cost: Around $18.98 for a pack of 300 tablets[1].

These prices are part of the Federal Supply Schedule (FSS) and are subject to change based on market conditions and regulatory updates.

Market Dynamics

The life sciences industry, including the market for Nifedipine, is influenced by several key factors:

Generic Competition

Generic drugs, including Nifedipine, face significant competition from other generic manufacturers. This competition can drive prices down, as multiple suppliers vie for market share. In 2025, the biopharma industry is expected to see increased competition from generic drugs and biosimilars, which could impact pricing strategies[3].

Regulatory Compliance

Manufacturers must comply with various regulatory requirements, including timely reporting of new NDCs and Average Manufacturer Prices (AMP) to Medicaid programs. This compliance ensures that drugs like Nifedipine remain covered under state Medicaid programs, which can influence pricing and market access[2].

Consumer Empowerment

The shift towards direct-to-consumer (DTC) marketing by pharmaceutical companies could impact how drugs like Nifedipine are priced and sold. Consumers are becoming more empowered with information, which can drive demand and influence pricing strategies. However, this trend is more relevant to branded and innovative therapies rather than generic drugs like Nifedipine[5].

Price Projections

Given the current market dynamics, here are some potential price projections for Nifedipine 60mg tablets (NDC: 51407-0623):

Short-Term Projections

  • 2025: Prices are likely to remain stable or see a slight decrease due to continued generic competition and regulatory pressures. A price range of $0.062 to $0.065 per unit is plausible.
  • 2026: As more generic versions enter the market, prices could drop further, potentially to $0.058 to $0.062 per unit.

Long-Term Projections

  • 2027-2030: The patent cliff and the loss of exclusivity for high-revenue products in the biopharma industry could lead to increased consolidation and mergers and acquisitions. While this may not directly impact Nifedipine, it could influence the overall market environment, potentially stabilizing prices or leading to minor fluctuations. A price range of $0.055 to $0.060 per unit is possible.

Impact of Digital Transformation and Innovation

The integration of technologies like gen AI and increased use of data is expected to boost operational efficiencies in the life sciences industry. While these advancements are more likely to impact innovative therapies, they could also lead to better supply chain management and cost reductions for generic drugs. This could result in more stable or slightly reduced prices for Nifedipine in the long term[3].

Key Takeaways

  • Current Pricing: Approximately $0.06327 per unit for Nifedipine 60mg tablets (NDC: 51407-0623).
  • Short-Term Projections: Stable or slightly decreased prices due to generic competition.
  • Long-Term Projections: Potential stabilization or minor fluctuations in prices influenced by industry-wide trends.
  • Market Dynamics: Regulatory compliance, consumer empowerment, and digital transformation will continue to shape the market.

FAQs

  1. What is the current wholesale price for Nifedipine 60mg tablets (NDC: 51407-0623)?

    • The current wholesale price is approximately $18.98 for a pack of 300 tablets, or $0.06327 per unit[1].
  2. How does generic competition affect the price of Nifedipine?

    • Generic competition can drive prices down as multiple suppliers compete for market share, leading to potential price reductions[3].
  3. What role does regulatory compliance play in pricing Nifedipine?

    • Regulatory compliance, including timely reporting of NDCs and AMP, ensures that the drug remains covered under state Medicaid programs, influencing pricing and market access[2].
  4. How might the shift to direct-to-consumer marketing impact Nifedipine prices?

    • While DTC marketing is more relevant to branded therapies, it could indirectly influence generic drug markets by changing consumer behavior and expectations, though this impact is likely minimal for Nifedipine[5].
  5. What are the long-term price projections for Nifedipine 60mg tablets?

    • Prices are projected to stabilize or see minor fluctuations, potentially ranging from $0.055 to $0.060 per unit, influenced by industry-wide trends and technological advancements[3].

Sources

  1. Drug Price Trends for NIFEDIPINE (EQV-CC) - DrugPatentWatch
  2. Manufacturer Release 118 - Medicaid
  3. 2025 life sciences outlook | Deloitte Insights
  4. Drug Name and National Drug Code (NDC) Reference Data Instructions - CMS
  5. 2025 Life Science Trends: Pharma Goes DTC - Definitive Healthcare

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.